MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber's hereditary optic neuropathy in healthy MtDNA mutations carriers.
Saved in:
| Title: | MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber's hereditary optic neuropathy in healthy MtDNA mutations carriers. |
|---|---|
| Authors: | Orssaud, Christophe1 (AUTHOR) christophe.orssaud@aphp.fr, Reynier, Pascal2,3 (AUTHOR) |
| Source: | Metabolomics. Oct2025, Vol. 21 Issue 5, p1-5. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15733882 |
|---|---|
| DOI: | 10.1007/s11306-025-02328-x |
